Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.30%, DAX +0.21%, CAC +0.15%

Jul 03 ,2025

  • Synopsis

    • European equity markets are set to open in positive territory amid Asia equities trading mixed Thursday in a generally directionless session. Hong Kong swung to declines as Australia/NZ sustain losses. Japan little changed, mainland China, South Korea and Taiwan higher. US futures marginally higher after S&P and Nasdaq extended record highs. Tech optimism was a notable tailwind with SOX index up 1.88%. US Big Tech mixed, but sharp gains in Tesla, Apple and Nvidia buoyed sentiment. US Treasuries recovering in Asia though JGBs/Australia bonds catching up to overnight weakness. Dollar index steadied with major currencies little changed. Crude oil and Bitcoin futures fading from earlier strength, gold steady.

    • In central banks updates, Bundesbank's Balz speech at 9:05CET at BaFinTech and Theurer speech at 9:30 at event hosted by National Assn of German Cooperative Banks (BVR). Other speakers at the latter is Chancellor Merz, on current aspects of economic and financial policy, the Chancellor also scheduled to meet with Bundesbank's Nagel in the afternoon. Bank of Spain's Escrivá speech at 14:00CET at event on the Spanish Economy jointly organised with CEMFI-UIMP (through Fri). ECB releases minutes of last MPC meeting at 13:30CET.

    • On the political front, EU's Dombrovskis, Hansen, Tzitzikostas among participants of College of Commissioners visit to Denmark (through Fri). Denmark will hold the Presidency of the Council of the European Union from 1-Jul. Les Recontres Economiques (through Sat) sees speeches from numerous politician, central bankers and company execs. Bruegel hosting event at 13:00CET title Who should be charged? The challenge of fairly allocating electricity system costs, includes exec from E.ON (EOAN.GR). Germany Jun new car registrations are due for release. Brainlab (BNLB.GR) expected to make its stock market debut.

    • Macroeconomic updates today include: Italy, Spain, Sweden Jun services PMI with final reads for Eurozone, France, Germany, UK, Switzerland Jun CPI

    • In corporate news, Redcare Pharmacy (RDC.GR) reported preliminary Q2 sales and said company is well on track to deliver all elements of its FY guidance. Still in the DACH region, Novartis (NOVN.SW) announced top-line results from Phase III GCAptAIN study evaluating Cosentyx in adults with newly diagnosed or relapsing giant cell arteritis. In France, Pluxee (PLX.FP) posted Q3 revenue and confirmed outlook for FY25 and FY26. From the Netherlands, Aperam (APAM.NA) confirmed Q2 outlook ahead of its Q2 earnings release

    • CMD/events: Catenai (CTAI.LN)

  • Politics/Macro/World News

    • ECB officials question whether euro has strengthened too much - FT

    • EU splits weaken its hand in crunch trade talks with Trump - Politico

    • Trump says he will put 20% tariff on Vietnam's exports - Reuters

    • France asks airlines to cut flights at Paris airports by 40% ahead of planned strike - Reuters

  • Top company news

    • Earnings/updates

      • RDC.GR (Redcare Pharmacy) -- reports preliminary Q2 revenue €709M vs FactSet €707.4M [2 est, €705-709.7M]

      • APAM.NA (Aperam) -- confirms Q2 outlook ahead of its Q2 earrings release on 31-Jul

      • PLX.FP (Pluxee) -- reports Q3 revenue €310M vs FactSet €310.0M [1 est]

      • GLJ.GR (GRENKE) -- reports leasing new business in Q2 of 2025 +9.8% y/y to €867.4M

      • A1OS.GR (All for One Group) -- adjusts FY25 guidance downward; announces €7M buyback

      • BLKB.SW (Basellandschaftliche Kantonalbank) -- reports (CHF105.5M) impairment on radicant investment; CEO and Chairman to leave, effective 2026

    • M&A

      • MB.IM (Mediobanca) -- CONSOB approves offer document in connection with Banca Monte dei Paschi di Siena's acquisition of Mediobanca (post EU close 2-Jul)

      • BPSO.IM (Banca Popolare di Sondrio) -- Italian Competition and Markets Authority conditionally approves BPER Banca's acquisition of Banca Popolare di Sondrio (post EU close 2-Jul)

      • EQT.SS (EQT AB) -- EQT Exeter Industrial Value Fund VI acquires 2.04M sq ft portfolio of modern logistics facilities in Manteca, California

      • MB.IM (Mediobanca) -- Banca Monte dei Paschi di Siena receives unconditional approval from the Italian Competition and Market Authority for the acquisition of Mediobanca (post EU close 2-Jul)

      • SHUR.BB (Shurgard Self Storage) -- acquires property in Amsterdam owned by Stevaco Vastgoed B.V. and Minerva Investments

      • COFA.FP (Coface) -- completes acquisition of Cedar Rose Group

      • INSE.LN (Inspired) -- Regent Acquisitions 2025 Ltd announces valid acceptances received for total ~232.9K Inspired shares

      • MAU.FP (Maurel et Prom) -- to acquire a 21% interest in the Sinu-9 gas block in Colombia, in addition to the acquisition of a 40% interest announced in February 2025, for $78.75M

    • Healthcare

      • ALCLS.FP (Cellectis SA) -- files $200M mixed shelf - F-3

      • IVA.FP (Inventiva) -- announces results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH in the Journal of Hepatology

      • SEPN (Septerna) -- announces collaboration with Novo Nordisk has become effective - 8-K

      • IRLAB.A.SS (IRLAB Therapeutics) -- publishes information document in connection with previously disclosed rights issue; subscription period commence today

      • NOVN.SW (Novartis) -- announces top-line results from Phase III GCAptAIN study evaluating Cosentyx in adults with newly diagnosed or relapsing giant cell arteritis

    • Other

      • AIR.FP (Airbus SE) -- reportedly near deal to sell additional A330Neo jets to Malaysia Airlines' parent group -- Reuters

      • MB.IM (Mediobanca) -- completes treasury share buyback

      • NDX1.GR (Nordex) -- receives orders totalling 135 MW in UK, Belgium and France

  • Key rating changes

    • Upgrades

      • ABN.NA (ABN AMRO Bank) -- to buy from reduce at Kepler Cheuvreux

    • Downgrades

      • BNR.GR (Brenntag) -- to hold from buy at Berenberg

      • FRES.LN (Fresnillo) -- to neutral from buy at UBS

      • ENTRA.NO (Entra ASA) -- to hold from buy at Pareto

    • Initiations

      • G24.GR (Scout24) -- initiated overweight at Cantor Fitzgerald

  • Data

    • Nikkei (0.08%) to 39732.47

    • Hang Seng (0.93%) to 23996.95

    • Shanghai Composite +0.13% to 3459.27

    • S&P futures +5.0 vs prior close of 6275.0

    • €-$ (0.0009) or (0.08%) to 1.1793

    • $-¥ +0.22 or +0.15% to 143.87

    • €-¥ +0.15 or +0.09% to 169.65

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE